Cardio-oncology: It takes two to translate

Science Translational Medicine

Volumn 5, Issue 187, 2013, Pages

  Moslehi, Javid ^a   Cheng, Susan ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CD135 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SUNITINIB; TRASTUZUMAB; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; BREAST CANCER; CANCER PATIENT; CANCER THERAPY; CARDIOLOGY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; GASTROINTESTINAL STROMAL TUMOR; HEART MUSCLE CELL; HUMAN; KIDNEY CANCER; ONCOLOGY; PRIORITY JOURNAL; SHORT SURVEY; STRESS;

ANGIOGENESIS INHIBITORS; ANIMALS; CORONARY VESSELS; HEART; INDOLES; MICROVESSELS; PERICYTES; PYRROLES;

EID: 84880548505     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3006490     Document Type: Short Survey

References (10)

1. G. M. Cote, D. B. Sawyer, B. A. Chabner, ERBB2 inhibition and heart failure. N. Engl. J. Med. 367, 2150-2153 (2012).
2. V. Chintalgattu, M. L. Rees, J. C. Culver, A. Goel, T. Jiffar, J. Zhang, K. Dunner Jr., S. Pati, J. A. Bankson, R. Pasqualini, W. Arap, N. S. Bryan, H. Taegtmeyer, R. R. Langley, H. Yao, M. E. Kupferman, M. L. Entman, M. E. Dickinson, A. Y. Khakoo, Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci. Transl. Med. 5, 187ra69 (2013).
3. R. S. Kerbel, Tumor angiogenesis. N. Engl. J. Med. 358, 2039-2049 (2008).
4. S. M. Bair, T. K. Choueiri, J. Moslehi, Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives. Trends Cardiovasc. Med. 23, 104-113 (2013).
5. T. F. Chu, M. A. Rupnick, R. Kerkela, S. M. Dallabrida, D. Zurakowski, L. Nguyen, K. Woulfe, E. Pravda, F. Cassiola, J. Desai, S. George, J. A. Morgan, D. M. Harris, N. S. Ismail, J. H. Chen, F. J. Schoen, A. D. Van den Abbeele, G. D. Demetri, T. Force, M. H. Chen, Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 370, 2011-2019 (2007).
6. V. Chintalgattu, D. Ai, R. R. Langley, J. Zhang, J. A. Bankson, T. L. Shih, A. K. Reddy, K. R. Coombes, I. N. Daher, S. Pati, S. S. Patel, J. S. Pocius, G. E. Taffet, L. M. Buja, M. L. Entman, A. Y. Khakoo, Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress. J. Clin. Invest. 120, 472-484 (2010).
7. N. de Jesus-Gonzalez, E. Robinson, J. Moslehi, B. D. Humphreys, Management of antiangiogenic therapyinduced hypertension. Hypertension 60, 607-615 (2012).
8. D. May, D. Gilon, V. Djonov, A. Itin, A. Lazarus, O. Gordon, C. Rosenberger, E. Keshet, Transgenic system for conditional induction and rescue of chronic myocardial hibernation provides insights into genomic programs of hibernation. Proc. Natl. Acad. Sci. U.S.A. 105, 282-287 (2008).
9. J. Moslehi, Y. A. Minamishima, J. Shi, D. Neuberg, D. M. Charytan, R. F. Padera, S. Signoretti, R. Liao, W. G. Kaelin Jr., Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 122, 1004-1016 (2010).
10. R. Bekeredjian, C. B. Walton, K. A. MacCannell, J. Ecker, F. Kruse, J. T. Outten, D. Sutcliffe, R. D. Gerard, R. K. Bruick, R. V. Shohet, Conditional HIF-1alpha expression produces a reversible cardiomyopathy. PLoS ONE 5, e11693 (2010).